Form 4 for CLDX Celldex Therapeutics, Inc.
Accepted 2025-12-08 00:00:00 ET · period of report 2025-12-04 · accession 0001838114-25-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-08 | 2025-12-04 | CLDX | Jimenez Freddy A. | SVP, GC | S - Sale | $29.10 | -4,166 | 30.8K | -12% | -$121.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-04 | S | D | 4,166 | $29.10 | 30,796 | D | — | — |